Abstract
Purpose
Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC) constitutes the largest subpopulation in EBV-associated tumors worldwide. To date, 44 mature EBV-encoded microRNAs (EBV miRNAs) have been identified, but their roles in EBVaGC development are still poorly understood. In this study, we aimed to investigate the roles and targets of ebv-miR-BART10-3p (BART10-3p) and ebv-miR-BART22 (BART22) in EBVaGC.
Methods
EBV miRNA expression in EBVaGCs was evaluated by deep sequencing and qRT-PCR, and relationships between BART10-3p or BART22 expression and clinicolpathological characteristics and survival rates of patients with EBVaGC were analyzed. The roles of BART10-3p and BART22 and their underlying mechanisms were further investigated through exogenous overexpression or silencing in EBVaGC cells, and validated in clinical EBVaGC tissue samples.
Results
BART10-3p and BART22 were found to be highly expressed in the EBVaGC cell lines SNU719 and YCCEL1. Higher expression of BART10-3p or BART22 in primary EBVaGC samples was significantly associated with lymph node metastasis and a worse 5-year overall survival. BART10-3p and BART22 promoted cell migration and invasion by targeting adenomatous polyposis coli (APC) and Dickkopf 1 (DKK1), thereby activating the Wnt signaling pathway and, consequently, upregulating downstream Twist and downregulating downstream E-cadherin. In 874 primary gastric carcinoma samples, APC and DKK1 were found to be lower expressed in EBVaGC than in EBV-negative samples, and their expression levels were inversely correlated with those of BART10-3p and BART22 in 71 EBVaGC samples.
Conclusions
From our data we conclude that BART10-3p and BART22 play vital roles in promoting EBVaGC metastasis by targeting APC and DKK1 and, subsequently, activating the Wnt signaling pathway, thereby providing novel prognostic biomarkers and potential therapeutic targets for EBVaGC.
Similar content being viewed by others
References
H.J. Delecluse, R. Feederle, B. O’Sullivan, P. Taniere, Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J. Clin. Pathol. 60, 1358–1364 (2007). https://doi.org/10.1136/jcp.2006.044586
S.C. Huang, K.F. Ng, K.H. Chen, J.T. Hsu, K.H. Liu, T.S. Yeh, T.C. Chen, Prognostic factors in Epstein-Barr virus-associated stage I-III gastric carcinoma: implications for a unique type of carcinogenesis. Oncol. Rep. 32, 530–538 (2014). https://doi.org/10.3892/or.2014.3234
M. Naseem, A. Barzi, C. Brezden-Masley, A. Puccini, M.D. Berger, R. Tokunaga, F. Battaglin, S. Soni, M. McSkane, W. Zhang, H.J. Lenz, Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat. Rev. 66, 15–22 (2018). https://doi.org/10.1016/j.ctrv.2018.03.006
K. Takada, Epstein-Barr virus and gastric carcinoma. Mol. Pathol. 53, 255–261 (2000)
T.C. Cheng, S.S. Hsieh, W.L. Hsu, Y.F. Chen, H.H. Ho, L.F. Sheu, Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity. Int. J. Oncol. 36, 151–160 (2010)
R. Hino, H. Uozaki, N. Murakami, T. Ushiku, A. Shinozaki, S. Ishikawa, T. Morikawa, T. Nakaya, T. Sakatani, K. Takada, M. Fukayama, Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 69, 2766–2774 (2009). https://doi.org/10.1158/0008-5472.CAN-08-3070
D. Iwakiri, Y. Eizuru, M. Tokunaga, K. Takada, Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res. 63, 7062–7067 (2003)
Q. Wang, S.W. Tsao, T. Ooka, J.M. Nicholls, H.W. Cheung, S. Fu, Y.C. Wong, X. Wang, Anti-apoptotic role of BARF1 in gastric cancer cells. Cancer Lett. 238, 90–103 (2006). https://doi.org/10.1016/j.canlet.2005.06.023
S.J. Chen, G.H. Chen, Y.H. Chen, C.Y. Liu, K.P. Chang, Y.S. Chang, H.C. Chen, Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One 5, e12745 (2010). https://doi.org/10.1371/journal.pone.0012745
A.R. Marquitz, A. Mathur, P.E. Chugh, D.P. Dittmer, N. Raab-Traub, Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells. J. Virol. 88, 1389–1393 (2014). https://doi.org/10.1128/JVI.02662-13
A.L. Treece, D.L. Duncan, W. Tang, S. Elmore, D.R. Morgan, R.L. Dominguez, O. Speck, M.O. Meyers, M.L. Gulley, Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns. Lab. Invest. 96, 661–671 (2016). https://doi.org/10.1038/labinvest.2016.33
J. Imig, N. Motsch, J.Y. Zhu, S. Barth, M. Okoniewski, T. Reineke, M. Tinguely, A. Faggioni, P. Trivedi, G. Meister, C. Renner, F.A. Grasser, microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res. 39, 1880–1893 (2011). https://doi.org/10.1093/nar/gkq1043
N. Motsch, J. Alles, J. Imig, J. Zhu, S. Barth, T. Reineke, M. Tinguely, S. Cogliatti, A. Dueck, G. Meister, C. Renner, F.A. Grässer, MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing. PLoS One 7, e42193 (2012). https://doi.org/10.1371/journal.pone.0042193
C.Y. Hsu, Y.H. Yi, K.P. Chang, Y.S. Chang, S.J. Chen, H.C. Chen, The Epstein-Barr Virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma. PLoS Pathog. 10, e1003974 (2014). https://doi.org/10.1371/journal.ppat.1003974
C.Y. Tsai, Y.Y. Liu, K.H. Liu, J.T. Hsu, T.C. Chen, C.T. Chiu, T.S. Yeh, Comprehensive profiling of virus microRNAs of Epstein-Barr virus-associated gastric carcinoma: highlighting the interactions of ebv-Bart9 and host tumor cells. J. Gastroenterol. Hepatol. 32, 82–91 (2017). https://doi.org/10.1111/jgh.13432
L.M. Cai, X.M. Lyu, W.R. Luo, X.F. Cui, Y.F. Ye, C.C. Yuan, Q.X. Peng, D.H. Wu, T.F. Liu, E. Wang, F.M. Marincola, K.T. Yao, W.Y. Fang, H.B. Cai, X. Li, EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene 34, 2156–2166 (2015). https://doi.org/10.1038/onc.2014.341
L. Cai, Y. Ye, Q. Jiang, Y. Chen, X. Lyu, J. Li, S. Wang, T. Liu, H. Cai, K. Yao, J.L. Li, X. Li, Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma. Nat. Commun. 6, 7353 (2015). https://doi.org/10.1038/ncomms8353
J. Zhao, Q. Liang, K.F. Cheung, W. Kang, R.W. Lung, J.H. Tong, K.F. To, J.J. Sung, J. Yu, Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells. Cancer 119, 304–312 (2013). https://doi.org/10.1002/cncr.27724
B.T. MacDonald, K. Tamai, X. He, Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9–26 (2009). https://doi.org/10.1016/j.devcel.2009.06.016
T. Zhan, N. Rindtorff, M. Boutros, Wnt signaling in cancer. Oncogene 36, 1461–1473 (2017). https://doi.org/10.1038/onc.2016.304
C.M. Cruciat, C. Niehrs, Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harb. Perspect. Biol. 5, a015081 (2013). https://doi.org/10.1101/cshperspect.a015081
A. Niida, T. Hiroko, M. Kasai, Y. Furukawa, Y. Nakamura, Y. Suzuki, S. Sugano, T. Akiyama, DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23, 8520–8526 (2004). https://doi.org/10.1038/sj.onc.1207892
M.V. Semenov, K. Tamai, B.K. Brott, M. Kuhl, S. Sokol, X. He, Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr. Biol. 11, 951–961 (2001)
A.M.G. Wong, K.L. Kong, J.W.H. Tsang, D.L.W. Kwong, X.-Y. Guan, Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 118, 698–710 (2012). https://doi.org/10.1002/cncr.26309
Q. Yan, Z. Zeng, Z. Gong, W. Zhang, X. Li, B. He, Y. Song, Q. Li, Y. Zeng, Q. Liao, P. Chen, L. Shi, S. Fan, B. Xiang, J. Ma, M. Zhou, X. Li, J. Yang, W. Xiong, G. Li, EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC. Oncotarget 6, 41766–41782 (2015). https://doi.org/10.18632/oncotarget.6155
K. Min, S.K. Lee, EBV miR-BART10-3p promotes cell proliferation and migration by targeting DKK1. Int. J. Biol. Sci. 15, 657–667 (2019). https://doi.org/10.7150/ijbs.30099
B.D. Edge, S.B. Compton, C.C. Fritz, A.G. Greene, F.L. Trotti (eds.), AJCC Cancer Staging Handbook, 7th edn. (Springer-Verlag, New York, 2010)
J.N. Chen, Y.G. Ding, Z.Y. Feng, H.G. Li, D. He, H. Du, B. Wu, C.K. Shao, Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China. J. Med. Virol. 82, 658–667 (2010). https://doi.org/10.1002/jmv.21731
M. Dong, H.Y. Wang, X.X. Zhao, J.N. Chen, Y.W. Zhang, Y. Huang, L. Xue, H.G. Li, H. Du, X.Y. Wu, C.K. Shao, Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma. Hum. Pathol. 53, 25–34 (2016). https://doi.org/10.1016/j.humpath.2016.02.007
L. Sun, F. Chen, W. Shi, L. Qi, Z. Zhao, J. Zhang, Prognostic impact of TAZ and beta-catenin expression in adenocarcinoma of the esophagogastric junction. Diagn. Pathol. 9, 125 (2014). https://doi.org/10.1186/1746-1596-9-125
D.K. Woo, H.S. Kim, H.S. Lee, Y.H. Kang, H.K. Yang, W.H. Kim, Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int. J. Cancer 95, 108–113 (2001)
A. Shinozaki-Ushiku, A. Kunita, M. Isogai, T. Hibiya, T. Ushiku, K. Takada, M. Fukayama, Profiling of virus-encoded microRNAs in Epstein-Barr Virus-associated gastric carcinoma and their roles in gastric carcinogenesis. J. Virol. 89, 5581–5591 (2015). https://doi.org/10.1128/JVI.03639-14
B.W. Kang, Y. Choi, O.K. Kwon, S.S. Lee, H.Y. Chung, W. Yu, H.I. Bae, A.N. Seo, H. Kang, S.K. Lee, S.W. Jeon, K. Hur, J.G. Kim, High level of viral microRNA-BART20-5p expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer. Oncotarget 8, 14988–14994 (2017). https://doi.org/10.18632/oncotarget.14744
W.T. Huang, C.W. Lin, EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-gamma-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma. Am. J. Pathol. 184, 1185–1197 (2014). https://doi.org/10.1016/j.ajpath.2013.12.024
J.Y.W. Chan, S.T.S. Wong, W.I. Wei, The role of Epstein-Barr virus-encoded microRNA BART7 status of resection margins in the prediction of local recurrence after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. Cancer 121, 2358–2366 (2015). https://doi.org/10.1002/cncr.29380
L. Cai, J. Li, X. Zhang, Y. Lu, J. Wang, X. Lyu, Y. Chen, J. Liu, H. Cai, Y. Wang, X. Li, Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma. Oncotarget 6, 7838–7850 (2015). https://doi.org/10.18632/oncotarget.3046
B. Kim, S.J. Byun, Y.A. Kim, J.E. Kim, B.L. Lee, W.H. Kim, M.S. Chang, Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Pathology 42, 58–65 (2010). https://doi.org/10.3109/00313020903356392
M. Tomita, M.Z. Dewan, N. Yamamoto, A. Kikuchi, N. Mori, Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes. Cancer Sci. 100, 807–812 (2009). https://doi.org/10.1111/j.1349-7006.2009.01121.x
J.A. Morrison, A.J. Klingelhutz, N. Raab-Traub, Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J. Virol. 77, 12276–12284 (2003)
K. Watanabe, J. Biesinger, M.L. Salmans, B.S. Roberts, W.T. Arthur, M. Cleary, B. Andersen, X. Xie, X. Dai, Integrative ChIP-seq/microarray analysis identifies a CTNNB1 target signature enriched in intestinal stem cells and colon cancer. PLoS One 9, e92317 (2014). https://doi.org/10.1371/journal.pone.0092317
Y. Nakamura, E. de Paiva Alves, G.J. Veenstra, S. Hoppler, Tissue- and stage-specific Wnt target gene expression is controlled subsequent to beta-catenin recruitment to cis-regulatory modules. Development 143, 1914–1925 (2016). https://doi.org/10.1242/dev.131664
E.A. Klein, R.K. Assoian, Transcriptional regulation of the cyclin D1 gene at a glance. J. Cell Sci. 121, 3853–3857 (2008). https://doi.org/10.1242/jcs.039131
M. Conacci-Sorrell, L. McFerrin, R.N. Eisenman, An overview of MYC and its interactome. Cold Spring Harb. Perspect. Med. 4, a014357 (2014). https://doi.org/10.1101/cshperspect.a014357
L. Xu, Y. Hou, G. Tu, Y. Chen, Y.E. Du, H. Zhang, S. Wen, X. Tang, J. Yin, L. Lang, K. Sun, G. Yang, X. Tang, M. Liu, Nuclear Drosha enhances cell invasion via an EGFR-ERK1/2-MMP7 signaling pathway induced by dysregulated miRNA-622/197 and their targets LAMC2 and CD82 in gastric cancer. Cell Death Dis. 8, e2642 (2017). https://doi.org/10.1038/cddis.2017.5
C.L. Xu, J.Z. Wang, X.P. Xia, C.W. Pan, X.X. Shao, S.L. Xia, S.X. Yang, B. Zheng, Rab11-FIP2 promotes colorectal cancer migration and invasion by regulating PI3K/AKT/MMP7 signaling pathway. Biochem. Biophys. Res. Commun. 470, 397–404 (2016). https://doi.org/10.1016/j.bbrc.2016.01.031
A. Krek, D. Grun, M.N. Poy, R. Wolf, L. Rosenberg, E.J. Epstein, P. MacMenamin, I. da Piedade, K.C. Gunsalus, M. Stoffel, N. Rajewsky, Combinatorial microRNA target predictions. Nat. Genet. 37, 495–500 (2005). https://doi.org/10.1038/ng1536
Z. Lin, X. Wan, R. Jiang, L. Deng, Y. Gao, J. Tang, Y. Yang, W. Zhao, X. Yan, K. Yao, B. Sun, Y. Chen, Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction. J. Virol. 88, 11872–11885 (2014). https://doi.org/10.1128/JVI.01867-14
N. Gaur, J. Gandhi, E.S. Robertson, S.C. Verma, R. Kaul, Epstein-Barr virus latent antigens EBNA3C and EBNA1 modulate epithelial to mesenchymal transition of cancer cells associated with tumor metastasis. Tumour Biol. 36, 3051–3060 (2015). https://doi.org/10.1007/s13277-014-2941-6
Acknowledgements
This work was supported by the National Natural Science Foundation of China (No. 81572309 to CKS, and No. 81502271 to MD), the Natural Science Foundation of Guangdong Province (No. 2017A030313502 to CKS), and Guangzhou Municipal Science and Technology Project (No. 201707010119 to CKS). We thank Prof. Qian Tao from the Chinese University of Hong Kong for supplying the YCCEL1 cell line as gift. We also thank Prof. Ling Xue from the First Affiliated Hospital, Sun Yat-sen University, Prof. Hai-gang Li from Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Prof. Yan Huang from the Sixth Affiliated Hospital, Sun Yat-sen University, and Prof. Hong Du from Guangzhou First People’s Hospital, Guangzhou Medical University for providing gastric carcinoma tissue samples.
Author information
Authors and Affiliations
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 6405 kb)
Rights and permissions
About this article
Cite this article
Dong, M., Gong, Lp., Chen, Jn. et al. EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway. Cell Oncol. 43, 901–913 (2020). https://doi.org/10.1007/s13402-020-00538-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-020-00538-0